Most psychedelic journeys don't happen in hospital clinics. Backed by $8.5 million in ARPA-H funding, UCSF neuroscientists led by Robin Carhart-Harris launched CANOPY—a global project tracking 3,000 real-world psychedelic users with remote surveys, brain imaging, and wearable sensors.